Over-expression of X-linked inhibitor of apoptosis protein slows presbycusis in C57BL/6J mice

Neurobiology of Aging

Volumn 31, Issue 7, 2010, Pages 1238-1249

  Wang, Jian ^a,b   Menchenton, Trevor ^b   Yin, Shankai ^a   Yu, Zhiping ^b   Bance, Manohar ^b   Morris, David P ^b   Moore, Craig S ^c   Korneluk, Robert G ^d   Robertson, George S ^c  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b DALHOUSIE UNIVERSITY   (Canada)

^c DALHOUSIE UNIVERSITY   (Canada)

^d CHILDREN S HOSPITAL OF EASTERN ONTARIO   (Canada)

Author keywords

Apoptosis; Mouse; Presbycusis; X linked inhibitor of apoptosis protein

Indexed keywords

X LINKED INHIBITOR OF APOPTOSIS;

AGE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; C57BL 6 MOUSE; CELL DEATH; CONTROLLED STUDY; EVOKED BRAIN STEM AUDITORY RESPONSE; GENOTYPE; HAIR CELL; HEARING LOSS; MALE; MOUSE; NONHUMAN; PATHOGENESIS; PRESBYACUSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSGENIC MOUSE; WILD TYPE;

ANIMALS; APOPTOSIS; COCHLEA; DISEASE PROGRESSION; EVOKED POTENTIALS, AUDITORY, BRAIN STEM; GENE EXPRESSION REGULATION; GENE THERAPY; HAIR CELLS, AUDITORY; HUMANS; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; PRESBYCUSIS; RECOMBINANT FUSION PROTEINS; X-LINKED INHIBITOR OF APOPTOSIS PROTEIN;

EID: 77952879957     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2008.07.016     Document Type: Article

References (74)

1. Alam S.A., Oshima T., Suzuki M., Kawase T., Takasaka T., Ikeda K. The expression of apoptosis-related proteins in the aged cochlea of Mongolian gerbils. Laryngoscope 2001, 111(3):528-534.
2. Chan D.K., Lieberman D.M., Musatov S., Goldfein J.A., Selesnick S.H., Kaplitt M.G. Protection against cisplatin-induced ototoxicity by adeno-associated virus-mediated delivery of the X-linked inhibitor of apoptosis protein is not dependent on caspase inhibition. Otol. Neurotol. 2007, 28(3):417-425.
3. Cooper L.B., Chan D.K., Roediger F.C., Shaffer B.R., Fraser J.F., Musatov S., Selesnick S.H., Kaplitt M.G. AAV-mediated delivery of the caspase inhibitor XIAP protects against cisplatin ototoxicity. Otol. Neurotol. 2006, 27(4):484-490.
4. Covell W.P., Rogers J.B. Pathologic changes in the inner ears of senile guinea pigs. Laryngoscope 1957, 67(2):118-129.
5. Crocker S.J., Liston P., Anisman H., Lee C.J., Smith P.D., Earl N., Thompson C.S., Park D.S., Korneluk R.G., Robertson G.S. Attenuation of MPTP-induced neurotoxicity and behavioural impairment in NSE-XIAP transgenic mice. Neurobiol. Dis. 2003, 12(2):150-161.
6. Davis R.R., Newlander J.K., Ling X., Cortopassi G.A., Krieg E.F., Erway L.C. Genetic basis for susceptibility to noise-induced hearing loss in mice. Hear Res. 2001, 155(1/2):82-90.
7. Dazert S., Feldman M.L., Keithley E.M. Cochlear spiral ganglion cell degeneration in wild-caught mice as a function of age. Hearing Res. 1996, 100(1/2):101-106.
8. Deveraux Q.L., Reed J.C. IAP family proteins-suppressors of apoptosis. Genes Dev. 1999, 13(3):239-252.
9. Deveraux Q.L., Roy N., Stennicke H.R., Van Arsdale T., Zhou Q., Srinivasula S.M., Alnemri E.S., Salvesen G.S., Reed J.C. IAPs block apoptotic events induced by caspase-8 and cytochrome c by direct inhibition of distinct caspases. EMBO J. 1998, 17(8):2215-2223.
10. Deveraux Q.L., Stennicke H.R., Salvesen G.S., Reed J.C. Endogenous inhibitors of caspases. J. Clin. Immunol. 1999, 19(6):388-398.
11. Deveraux Q.L., Takahashi R., Salvesen G.S., Reed J.C. X-linked IAP is a direct inhibitor of cell-death proteases. Nature 1997, 388(6639):300-304.
12. Ding D.-L., Wang J., Salvi R.J., Henderson D., Hu B.-H., McFadden S.L., Mueller M. Selective loss of inner hair cells and type-I ganglion neurons in carboplatin-treated chinchillas. Ototoxicity: Basic Science and Clinical Implications 1999, vol. 884:152-170. New York Academy of Sciences, New York.
13. Ding D., McFadden S., Salvi R. Cochlear hair cell densities and inner-ear staining techniques. Handbook of Mouse Auditory Research-From Behavior to Molecular Biology 2001, 189-204. CRC Press, New York. J.F. Willott (Ed.).
14. Ding D.L., McFadden S.L., Wang J., Hu B.H., Salvi R.J. Age- and strain-related differences in dehydrogenase activity and glycogen levels in CBA and C57 mouse cochleas. Audiol. Neurootol. 1999, 4(2):55-63.
15. Eckelman B.P., Salvesen G.S., Scott F.L. Human inhibitor of apoptosis proteins: why XIAP is the black sheep of the family. EMBO Rep. 2006, 7(10):988-994.
16. Ernfors P., Duan M.L., ElShamy W.M., Canlon B. Protection of auditory neurons from aminoglycoside toxicity by neurotrophin-3. Nat. Med. 1996, 2(4):463-467.
17. Erway L.C., Shiau Y.W., Davis R.R., Krieg E.F. Genetics of age-related hearing loss in mice. III. Susceptibility of inbred and F1 hybrid strains to noise-induced hearing loss. Hear Res. 1996, 93(1/2):181-187.
18. Erway L.C., Willott J.F., Archer J.R., Harrison D.E. Genetics of age-related hearing loss in mice. I. Inbred and F1 hybrid strains. Hear Res. 1993, 65(1/2):125-132.
19. Felder E., Schrott-Fischer A. Quantitative evaluation of myelinated nerve fibres and hair cells in cochleae of humans with age-related high-tone hearing loss. Hear Res. 1995, 91(1/2):19-32.
20. Garetz S.L., Rhee D.J., Schacht J. Sulfhydryl compounds and antioxidants inhibit cytotoxicity to outer hair cells of a gentamicin metabolite in vitro. Hearing Res. 1994, 77(1/2):75-80.
21. Harding G.W., Bohne B.A., Vos J.D. The effect of an age-related hearing loss gene (AHL) on noise-induced hearing loss and cochlear damage from low-frequency noise. Hear Res. 2005, 204(1/2):90-100.
22. Henry K.R., Chole R.A. Genotypic differences in behavioral, physiological and anatomical expressions of age-related hearing loss in the laboratory mouse. Audiology 1980, 19(5):369-383.
23. Holcik M. Translational upregulation of the X-linked inhibitor of apoptosis. Ann. N.Y. Acad. Sci. 2003, 1010:249-258.
24. Holcik M., Gibson H., Korneluk R.G. XIAP: apoptotic brake and promising therapeutic target. Apoptosis 2001, 6(4):253-261.
25. Holcik M., Lefebvre C., Yeh C., Chow T., Korneluk R.G. A new internal-ribosome-entry-site motif potentiates XIAP-mediated cytoprotection. Nat. Cell Biol. 1999, 1(3):190-192.
26. Hunter K.P., Willott J.F. Aging and the auditory brainstem response in mice with severe or minimal presbycusis. Hearing Res. 1987, 30:207-218.
27. Igaki T., Kanda H., Yamamoto-Goto Y., Kanuka H., Kuranaga E., Aigaki T., Miura M. Eiger, a TNF superfamily ligand that triggers the Drosophila JNK pathway. EMBO J. 2002, 21(12):3009-3018.
28. Iwai H., Lee S., Inaba M., Sugiura K., Tomoda K., Yamashita T., Ikehara S. Prevention of accelerated presbycusis by bone marrow transplantation in senescence-accelerated mice. Bone Marrow Transplant. 2001, 28(4):323-328.
29. Jimenez A.M., Stagner B.B., Martin G.K., Lonsbury-Martin B.L. Susceptibility of DPOAEs to sound overexposure in inbred mice with AHL. J. Assoc. Res. Otolaryngol. 2001, 2(3):233-245.
30. Johnson K.R., Erway L.C., Cook S.A., Willott J.F., Zheng Q.Y. A major gene affecting age-related hearing loss in C57BL/6J mice. Hear Res. 1997, 114(1/2):83-92.
31. Johnson K.R., Zheng Q.Y., Erway L.C. A major gene affecting age-related hearing loss is common to at least ten inbred strains of mice. Genomics 2000, 70(2):171-180.
32. Kaur S., Wang F., Venkatraman M., Arsura M. X-linked inhibitor of apoptosis (XIAP) inhibits c-Jun N-terminal kinase 1 (JNK1) activation by transforming growth factor beta1 (TGF-beta1) through ubiquitin-mediated proteosomal degradation of the TGF-beta1-activated kinase 1 (TAK1). J. Biol. Chem. 2005, 280(46):38599-38608.
33. Keithley E.M., Ryan A.F., Feldman M.L. Cochlear degeneration in aged rats of four strains. Hearing Res. 1992, 59(2):171-178.
34. Kujoth G.C., Hiona A., Pugh T.D., Someya S., Panzer K., Wohlgemuth S.E., Hofer T., Seo A.Y., Sullivan R., Jobling W.A., Morrow J.D., Van Remmen H., Sedivy J.M., Yamasoba T., Tanokura M., Weindruch R., Leeuwenburgh C., Prolla T.A. Mitochondrial DNA mutations, oxidative stress, and apoptosis in mammalian aging. Science 2005, 309(5733):481-484.
35. Lautermann J., McLaren J., Schacht J. Glutathione protection against gentamicin ototoxicity depends on nutritional status. Hearing Res. 1995, 86(1/2):15-24.
36. Li H.S., Borg E. Age-related loss of auditory sensitivity in two mouse genotypes. Acta Otolaryngol. 1991, 111(5):827-834.
37. Liston P., Roy N., Tamai K., Lefebvre C., Baird S., Cherton-Horvat G., Farahani R., McLean M., Ikeda J.E., MacKenzie A., Korneluk R.G. Suppression of apoptosis in mammalian cells by NAIP and a related family of IAP genes. Nature 1996, 379(6563):349-353.
38. Liu W., Staecker H., Stupak H., Malgrange B., Lefebvre P., Van De Water T.R. Caspase inhibitors prevent cisplatin-induced apoptosis of auditory sensory cells. Neuroreport 1998, 9(11):2609-2614.
39. Matsui J.I., Haque A., Huss D., Messana E.P., Alosi J.A., Roberson D.W., Cotanche D.A., Dickman J.D., Warchol M.E. Caspase inhibitors promote vestibular hair cell survival and function after aminoglycoside treatment in vivo. J. Neurosci. 2003, 23(14):6111-6122.
40. McFadden S.L., Ding D., Salvi R. Anatomical, metabolic and genetic aspects of age-related hearing loss in mice. Audiology 2001, 40(6):313-321.
41. Mikaelian D.O. Development and degeneration of hearing in the C57/b16 mouse: relation of electrophysiologic responses from the round window and cochlear nucleus to cochlear anatomy and behavioral responses. Laryngoscope 1979, 89:1-15.
42. Ohinata Y., Miller J.M., Schacht J. Protection from noise-induced lipid peroxidation and hair cell loss in the cochlea. Brain Res. 2003, 966(2):265-273.
43. Ohlemiller K.K. Age-related hearing loss: the status of Schuknecht's typology. Curr. Opin. Otolaryngol. Head Neck Surg. 2004, 12(5):439-443.
44. Ohlemiller K.K., Gagnon P.M. Apical-to-basal gradients in age-related cochlear degeneration and their relationship to " primary" loss of cochlear neurons. J. Comp. Neurol. 2004, 479(1):103-116.
45. Ohlemiller K.K., Gagnon P.M. Cellular correlates of progressive hearing loss in 129S6/SvEv mice. J. Comp. Neurol. 2004, 469(3):377-390.
46. Ohlemiller K.K., Lett J.M., Gagnon P.M. Cellular correlates of age-related endocochlear potential reduction in a mouse model. Hear Res. 2006, 220(1/2):10-26.
47. Ohlemiller K.K., Wright J.S., Heidbreder A.F. Vulnerability to noise-induced hearing loss in 'middle-aged' and young adult mice: a dose-response approach in CBA, C57BL, and BALB inbred strains. Hear Res. 2000, 149(1/2):239-247.
48. Parham K., Willott J.F. Acoustic startle response in young and aging C57BL/6J and CBA/J mice. Behav. Neurosci. 1988, 102(6):881-886.
49. Pickles J.O. Mutation in mitochondrial DNA as a cause of presbyacusis. Audiol. Neurootol. 2004, 9(1):23-33.
50. Robertson G.S., Crocker S.J., Nicholson D.W., Schulz J.B. Neuroprotection by the inhibition of apoptosis. Brain Pathol. 2000, 10(2):283-292.
51. Roy N., Deveraux Q.L., Takahashi R., Salvesen G.S., Reed J.C. The c-IAP-1 and c-IAP-2 proteins are direct inhibitors of specific caspases. EMBO J. 1997, 16(23):6914-6925.
52. Salvesen G.S., Duckett C.S. IAP proteins: blocking the road to death's door. Nat. Rev. Mol. Cell Biol. 2002, 3(6):401-410.
53. Schoemaker M.H., Ros J.E., Homan M., Trautwein C., Liston P., Poelstra K., van Goor H., Jansen P.L., Moshage H. Cytokine regulation of pro- and anti-apoptotic genes in rat hepatocytes: NF-kappaB-regulated inhibitor of apoptosis protein 2 (cIAP2) prevents apoptosis. J. Hepatol. 2002, 36(6):742-750.
54. Schotte P., Declercq W., Van Huffel S., Vandenabeele P., Beyaert R. Non-specific effects of methyl ketone peptide inhibitors of caspases. FEBS Lett. 1999, 442(1):117-121.
55. Schuknecht H.F. Further Observations on the Pathology of Presbycusis. Arch. Otolaryngol. 1964, 80:369-382.
56. Schuknecht H.F., Gacek M.R. Cochlear pathology in presbycusis. Ann. Otol. Rhinol. Laryngol. 1993, 102(1 Pt 2):1-16.
57. Seidman M.D., Ahmad N., Bai U. Molecular mechanisms of age-related hearing loss. Ageing Res. Rev. 2002, 1(3):331-343.
58. Simons M., Beinroth S., Gleichmann M., Liston P., Korneluk R.G., MacKenzie A.E., Bahr M., Klockgether T., Robertson G.S., Weller M., Schulz J.B. Adenovirus-mediated gene transfer of inhibitors of apoptosis protein delays apoptosis in cerebellar granule neurons. J. Neurochem. 1999, 72(1):292-301.
59. Spicer S.S., Schulte B.A. Spiral ligament pathology in quiet-aged gerbils. Hear Res. 2002, 172(1/2):172-185.
60. Spongr V.P., Flood D.G., Frisina R.D., Salvi R.J. Quantitative measure of hair cell loss in CBA and C57BL/6 mice throughout their life spans. J. Acoust. Soc. Am. 1997, 101:3546-3553.
61. Stehlik C., de Martin R., Kumabashiri I., Schmid J.A., Binder B.R., Lipp J. Nuclear factor (NF)-kappaB-regulated X-chromosome-linked IAP gene expression protects endothelial cells from tumor necrosis factor alpha-induced apoptosis. J. Exp. Med. 1998, 188(1):211-216.
62. Suckfuell M., Canis M., Strieth S., Scherer H., Haisch A. Intratympanic treatment of acute acoustic trauma with a cell-permeable JNK ligand: a prospective randomized phase I/II study. Acta Otolaryngol. 2007, 127(9):938-942.
63. Suzuki Y., Nakabayashi Y., Takahashi R. Ubiquitin-protein ligase activity of X-linked inhibitor of apoptosis protein promotes proteasomal degradation of caspase-3 and enhances its anti-apoptotic effect in Fas-induced cell death. Proc. Natl. Acad. Sci. U.S.A. 2001, 98(15):8662-8667.
64. Trapp T., Korhonen L., Besselmann M., Martinez R., Mercer E.A., Lindholm D. Transgenic mice overexpressing XIAP in neurons show better outcome after transient cerebral ischemia. Mol. Cell. Neurosci. 2003, 23(2):302-313.
65. Wang J., Ding D., Shulman A., Stracher A., Salvi R.J. Leupeptin protects sensory hair cells from acoustic trauma. Neuroreport 1999, 10(4):811-816.
66. Wang J., Ladrech S., Pujol R., Brabet P., Van De Water T.R., Puel J.L. Caspase inhibitors, but not c-Jun NH2-terminal kinase inhibitor treatment, prevent cisplatin-induced hearing loss. Cancer Res. 2004, 64(24):9217-9224.
67. Wei X., Zhao L., Liu J., Dodel R.C., Farlow M.R., Du Y. Minocycline prevents gentamicin-induced ototoxicity by inhibiting p38 MAP kinase phosphorylation and caspase 3 activation. Neuroscience 2005, 131(2):513-521.
68. Willott J.F. Effects of aging, hearing loss, and anatomical location on thresholds of inferior colliculus neurons in C57BL/6 and CBA mice. J. Neurophysiol. 1986, 56(2):391-408.
69. Willott J.F., Turner J.G., Carlson S., Ding D., Seegers Bross L., Falls W.A. The BALB/c mouse as an animal model for progressive sensorineural hearing loss. Hear Res. 1998, 115(1/2):162-174.
70. Wu Y.J., Muldoon L.L., Neuwelt E.A. The chemoprotective agent N-acetylcysteine blocks cisplatin-induced apoptosis through caspase signaling pathway. J. Pharmacol. Exp. Ther. 2005, 312(2):424-431.
71. Xu D., Bureau Y., McIntyre D.C., Nicholson D.W., Liston P., Zhu Y., Fong W.G., Crocker S.J., Korneluk R.G., Robertson G.S. Attenuation of ischemia-induced cellular and behavioral deficits by X chromosome-linked inhibitor of apoptosis protein overexpression in the rat hippocampus. J. Neurosci. 1999, 19(12):5026-5033.
72. Zhang M., Liu W., Ding D., Salvi R. Pifithrin-alpha suppresses p53 and protects cochlear and vestibular hair cells from cisplatin-induced apoptosis. Neuroscience 2003, 120(1):191-205.
73. Zheng J.L., Stewart R.R., Gao W.Q. Neurotrophin-4/5 enhances survival of cultured spiral ganglion neurons and protects them from cisplatin neurotoxicity. J. Neurosci. 1995.
74. Zheng Y., Ikeda K., Nakamura M., Takasaka T. Endonuclease cleavage of DNA in the aged cochlea of Mongolian gerbil. Hear Res. 1998, 126(1/2):11-18.